Vestagen Technical Textiles, Inc., announced four key appointments to support expanded commercialization of Vestex, the first in a new class of medical devices based on active barrier protective fabrics that are clinically proven to prevent or reduce the acquisition and retention of contaminants.

Vestex is engineered to have robust liquid repellency and embedded antimicrobial properties, superior durability and enhanced breathability. The result is protective garments for everyday use that are comfortable, durable and competitively priced.

David B. Nash, MD, MBA, has been named a Director. He is the Founding Dean and Dr. Raymond C. and Doris N. Grandon Professor of Health Policy at the Jefferson School of Population Health of Thomas Jefferson University.

Dr. Nash is internationally recognized for his work in outcomes management, quality improvement and medical staff development. He regularly appears on Modern Healthcare's list of "Most Powerful Persons in Healthcare" and his educational, consulting and healthcare business activities cover a wide scope.

A former Deputy Editor of Annals of Internal Medicine, Dr. Nash is Editor-in-Chief of four scientific journals. He is also a member of the Board of Directors of Humana, Inc.

"Dr. Nash brings a wealth of medical and healthcare sector knowledge and experience to Vestagen," said Dale R. Pfost, PhD, Executive Chairman of Vestagen. "His expertise in quality issues and outcomes research, and his wide-ranging interests in the science and business of healthcare, will make him an invaluable addition as we commercialize the first medical uniforms designed to function as protective medical devices."

Vestagen also added three key executives. Dawn Clarke joins as Chief Technology Officer, Amber Mitchell joins as Vice President of Regulatory Affairs and JD Spangler joins as Chief Commercial Officer.

Clarke leads technical product development and supply chain for Vestagen. She brings extensive product development expertise and has over 25 years of textiles experience, including global identification of new technologies for military and commercial applications. Most recently she was Vice President of Technology for Patriarch Partners Textiles Platform.

Mitchell directs regulatory and government affairs activities for Vestagen. She is an experienced regulatory and public affairs expert who has held leadership positions in both federal government and commercial settings.

Mitchell has over 15 years of experience developing standards and training programs focused on healthcare worker safety, infection prevention and the management of multi-drug resistant organisms.  Most recently she was Director of Professional Education and Public Affairs at Johnson & Johnson.

Spangler leads Vestagen's domestic and international marketing and sales efforts. He has more than 20 years of consumer product, category management and sales and marketing experience at leading consumer product companies. Most recently Spangler was Vice President of Global Business Development for Hanesbrands, a worldwide leader in apparel manufacturing, branding and retailing.

"These senior-level appointments strengthen our leadership team with highly experienced individuals who bring a track record of success, along with deep knowledge of our markets," said Uncas "Ben" B. Favret III, president and CEO of Vestagen.

"Dawn has the proven ability to identify break-through textile technologies and engineer solutions that uniquely address consumer needs. Amber's extensive experience in regulatory and enforcement make her the perfect choice to lead the process to secure FDA clearance for Vestex as a Class 2 medical device. JD's drive and customer focus are matched by his expertise in textiles, apparel and consumer product marketing. With our core executive team in place, we are well-positioned for rapid near-term, as well as longer-term growth."